Nia Tatsis
Förmögenhet: 23 M $ per 2026-06-30
Förmögenhet: 23 M $ per 2026-06-30
Nia Tatsis currently serves as Chief Regulatory & Quality Officer, Director, EVP at Vertex Pharmaceuticals, Inc. since 2025, Independent Director at Odyssey Therapeutics, Inc. since 2025, and Member-Leadership Council at the International Institute of New England since 2021.
Former roles include Director at Verve Therapeutics, Inc. from 2024 to 2025 and Vice President & Head-Global Regulatory Affairs at Genzyme Corp.
from 2014 to 2017.
Education includes undergraduate studies at Temple University (Pennsylvania) and a doctorate from the University of Vermont.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-02 | 45 321 ( 0,02 % ) | 23 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Direktör/Styrelseledamot | 2025-10-10 |
| ODYSSEY THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-09-01 |
International Institute of New England
International Institute of New England Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for immigration and foreign communities | Företagsledare/Principal | 2021-01-01 |
| Företag | Position | Slut |
|---|---|---|
| VERE THER | Direktör/Styrelseledamot | 2025-07-25 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | 2017-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute of New England
International Institute of New England Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for immigration and foreign communities | Commercial Services |
Verve Therapeutics, Inc.
Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån